Solvay Pharmaceuticals, Inc. Misses Out on Dutch H1N1 Vaccine Contract

Bookmark and Share

Reuters -- Belgium’s Solvay said on Monday it missed out on a Dutch government contract to supply the Netherlands with an H1N1 flu virus vaccine because it could not supply the product within the required timeframe.

MORE ON THIS TOPIC